Astria Therapeutics (ATXS) News Today $5.36 -0.21 (-3.77%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATXS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Astria Therapeutics Inc News (ATXS) - Investing.comJune 25, 2025 | investing.comAstria Therapeutics (NASDAQ:ATXS) Shares Cross Above Fifty Day Moving Average - Here's WhyJune 21, 2025 | marketbeat.comAstria Therapeutics' (ATXS) Buy Rating Reiterated at HC WainwrightJune 13, 2025 | marketbeat.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Recommendation of "Buy" from AnalystsJune 12, 2025 | marketbeat.comEquities Analysts Set Expectations for ATXS FY2026 EarningsJune 10, 2025 | marketbeat.comAstria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual CongressJune 6, 2025 | businesswire.comAstria Therapeutics at Jefferies Conference: Strategic Pipeline InsightsJune 6, 2025 | investing.comAstria Therapeutics to Present at Upcoming Jefferies Global Healthcare ConferenceMay 28, 2025 | finance.yahoo.comAstria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema WorkshopMay 23, 2025 | businesswire.comAstria Therapeutics to Present at Upcoming Eastern Allergy ConferenceMay 22, 2025 | businesswire.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Shares Sold by VR Adviser LLCMay 22, 2025 | marketbeat.comVestal Point Capital LP Acquires 180,000 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS)May 21, 2025 | marketbeat.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Rating of "Buy" from AnalystsMay 20, 2025 | marketbeat.comPatient Square Capital LP Boosts Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 16, 2025 | marketbeat.comAstria Therapeutics Shares Rise Following Update on In-Development DrugsMay 13, 2025 | marketwatch.comAstria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 13, 2025 | businesswire.comFcpm Iii Services B.V. Purchases New Position in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 11, 2025 | marketbeat.comIs Astria Therapeutics, Inc. (ATXS) the Low Risk High Reward Stock Set to Triple by 2030?May 10, 2025 | insidermonkey.comRaymond James Financial Inc. Buys Shares of 79,044 Astria Therapeutics, Inc. (NASDAQ:ATXS)May 9, 2025 | marketbeat.comInvesco Ltd. Has $161,000 Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS)May 6, 2025 | marketbeat.comCantor Fitzgerald Comments on ATXS FY2025 EarningsMay 3, 2025 | marketbeat.comAstria Therapeutics (ATXS) to Release Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comAstria Therapeutics reports progress in HAE drug trialMay 2, 2025 | investing.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 2, 2025 | businesswire.comAstria Therapeutics (NASDAQ:ATXS) Stock Rating Upgraded by Cantor FitzgeraldMay 2, 2025 | marketbeat.comAstria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & ImmunologyMay 1, 2025 | finance.yahoo.comAdage Capital Partners GP L.L.C. Sells 54,743 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS)May 1, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Astria Therapeutics (ATXS) with Overweight RecommendationApril 30, 2025 | msn.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Given Consensus Recommendation of "Buy" by BrokeragesApril 25, 2025 | marketbeat.comRaymond James Financial Inc. Takes $707,000 Position in Astria Therapeutics, Inc. (NASDAQ:ATXS)April 7, 2025 | marketbeat.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 2, 2025 | businesswire.comAstria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Recommendation of "Buy" from BrokeragesMarch 30, 2025 | marketbeat.comLifesci Capital Issues Negative Estimate for ATXS EarningsMarch 15, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for ATXS Q1 Earnings?March 15, 2025 | marketbeat.comWedbush Reduces Earnings Estimates for Astria TherapeuticsMarch 15, 2025 | marketbeat.comAstria Therapeutics price target raised to $28 from $27 at WedbushMarch 12, 2025 | markets.businessinsider.comAstria Therapeutics (NASDAQ:ATXS) Given Buy Rating at HC WainwrightMarch 12, 2025 | marketbeat.comWedbush Keeps Their Buy Rating on Astria Therapeutics (ATXS)March 12, 2025 | markets.businessinsider.comAstria Therapeutics (ATXS) Gets a Buy from WedbushMarch 12, 2025 | markets.businessinsider.comAstria Therapeutics (NASDAQ:ATXS) Announces Quarterly Earnings ResultsMarch 12, 2025 | marketbeat.comAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 4, 2025 | businesswire.comTD Cowen Remains a Buy on Astria Therapeutics (ATXS)March 1, 2025 | markets.businessinsider.comHC Wainwright Reaffirms "Buy" Rating for Astria Therapeutics (NASDAQ:ATXS)February 28, 2025 | marketbeat.comAstria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary AngioedemaFebruary 27, 2025 | businesswire.comAstria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care ConferenceFebruary 25, 2025 | finance.yahoo.comAstria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care ConferenceFebruary 25, 2025 | businesswire.comAstria Therapeutics (ATXS) to Release Earnings on MondayFebruary 24, 2025 | marketbeat.comCalculating The Intrinsic Value Of Astria Therapeutics, Inc. (NASDAQ:ATXS)February 22, 2025 | finance.yahoo.comAstria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint CongressFebruary 20, 2025 | finance.yahoo.comAstria Therapeutics (NASDAQ:ATXS) Shares Pass Below Fifty Day Moving Average - What's Next?February 18, 2025 | marketbeat.com Get Astria Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATXS and its competitors with MarketBeat's FREE daily newsletter. Email Address ATXS Media Mentions By Week ATXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATXS News Sentiment▼0.930.90▲Average Medical News Sentiment ATXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATXS Articles This Week▼22▲ATXS Articles Average Week Get Astria Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ocular Therapeutix News Today Travere Therapeutics News Today BGM Group News Today Structure Therapeutics News Today CureVac News Today Calliditas Therapeutics AB (publ) News Today Dyne Therapeutics News Today Amphastar Pharmaceuticals News Today Niagen Bioscience News Today Aurinia Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATXS) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXS Stock Alerts